129 related articles for article (PubMed ID: 36720449)
1. Bioconjugation studies of an EGF-R targeting ligand on dendronized iron oxide nanoparticles to target head and neck cancer cells.
Freis B; Ramírez MLÁ; Furgiuele S; Journe F; Cheignon C; Charbonnière LJ; Henoumont C; Kiefer C; Mertz D; Affolter-Zbaraszczuk C; Meyer F; Saussez S; Laurent S; Tasso M; Bégin-Colin S
Int J Pharm; 2023 Mar; 635():122654. PubMed ID: 36720449
[TBL] [Abstract][Full Text] [Related]
2. Anti-HER2 antibody and ScFvEGFR-conjugated antifouling magnetic iron oxide nanoparticles for targeting and magnetic resonance imaging of breast cancer.
Chen H; Wang L; Yu Q; Qian W; Tiwari D; Yi H; Wang AY; Huang J; Yang L; Mao H
Int J Nanomedicine; 2013; 8():3781-94. PubMed ID: 24124366
[TBL] [Abstract][Full Text] [Related]
3. Effect of the Size and Shape of Dendronized Iron Oxide Nanoparticles Bearing a Targeting Ligand on MRI, Magnetic Hyperthermia, and Photothermia Properties-From Suspension to In Vitro Studies.
Freis B; Ramirez MLA; Kiefer C; Harlepp S; Iacovita C; Henoumont C; Affolter-Zbaraszczuk C; Meyer F; Mertz D; Boos A; Tasso M; Furgiuele S; Journe F; Saussez S; Bégin-Colin S; Laurent S
Pharmaceutics; 2023 Mar; 15(4):. PubMed ID: 37111590
[TBL] [Abstract][Full Text] [Related]
4. Unveiling the role of surface, size, shape and defects of iron oxide nanoparticles for theranostic applications.
Cotin G; Blanco-Andujar C; Perton F; Asín L; de la Fuente JM; Reichardt W; Schaffner D; Ngyen DV; Mertz D; Kiefer C; Meyer F; Spassov S; Ersen O; Chatzidakis M; Botton GA; Hénoumont C; Laurent S; Greneche JM; Teran FJ; Ortega D; Felder-Flesch D; Begin-Colin S
Nanoscale; 2021 Sep; 13(34):14552-14571. PubMed ID: 34473175
[TBL] [Abstract][Full Text] [Related]
5. Gold-coated magnetic nanoparticle as a nanotheranostic agent for magnetic resonance imaging and photothermal therapy of cancer.
Eyvazzadeh N; Shakeri-Zadeh A; Fekrazad R; Amini E; Ghaznavi H; Kamran Kamrava S
Lasers Med Sci; 2017 Sep; 32(7):1469-1477. PubMed ID: 28674789
[TBL] [Abstract][Full Text] [Related]
6. Identification of epidermal growth factor receptor-positive glioblastoma using lipid-encapsulated targeted superparamagnetic iron oxide nanoparticles in vitro.
Chen HL; Hsu FT; Kao YJ; Liu HS; Huang WZ; Lu CF; Tsai PH; Ali AAA; Lee GA; Chen RJ; Chen CY
J Nanobiotechnology; 2017 Nov; 15(1):86. PubMed ID: 29166921
[TBL] [Abstract][Full Text] [Related]
7. Active targeting theranostic iron oxide nanoparticles for MRI and magnetic resonance-guided focused ultrasound ablation of lung cancer.
Wang Z; Qiao R; Tang N; Lu Z; Wang H; Zhang Z; Xue X; Huang Z; Zhang S; Zhang G; Li Y
Biomaterials; 2017 May; 127():25-35. PubMed ID: 28279919
[TBL] [Abstract][Full Text] [Related]
8. Magnetic targeting combined with active targeting of dual-ligand iron oxide nanoprobes to promote the penetration depth in tumors for effective magnetic resonance imaging and hyperthermia.
Chen L; Wu Y; Wu H; Li J; Xie J; Zang F; Ma M; Gu N; Zhang Y
Acta Biomater; 2019 Sep; 96():491-504. PubMed ID: 31302299
[TBL] [Abstract][Full Text] [Related]
9. Folic acid on iron oxide nanoparticles: platform with high potential for simultaneous targeting, MRI detection and hyperthermia treatment of lymph node metastases of prostate cancer.
Bonvin D; Bastiaansen JAM; Stuber M; Hofmann H; Mionić Ebersold M
Dalton Trans; 2017 Sep; 46(37):12692-12704. PubMed ID: 28914298
[TBL] [Abstract][Full Text] [Related]
10. Iron oxide nanoparticles - In vivo/in vitro biomedical applications and in silico studies.
Nedyalkova M; Donkova B; Romanova J; Tzvetkov G; Madurga S; Simeonov V
Adv Colloid Interface Sci; 2017 Nov; 249():192-212. PubMed ID: 28499604
[TBL] [Abstract][Full Text] [Related]
11. Hyperthermia treatment of cancer cells by the application of targeted silk/iron oxide composite spheres.
Kucharczyk K; Kaczmarek K; Jozefczak A; Slachcinski M; Mackiewicz A; Dams-Kozlowska H
Mater Sci Eng C Mater Biol Appl; 2021 Jan; 120():111654. PubMed ID: 33545822
[TBL] [Abstract][Full Text] [Related]
12. EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma.
Hadjipanayis CG; Machaidze R; Kaluzova M; Wang L; Schuette AJ; Chen H; Wu X; Mao H
Cancer Res; 2010 Aug; 70(15):6303-12. PubMed ID: 20647323
[TBL] [Abstract][Full Text] [Related]
13. Cetuximab-Coated Thermo-Sensitive Liposomes Loaded with Magnetic Nanoparticles and Doxorubicin for Targeted EGFR-Expressing Breast Cancer Combined Therapy.
Dorjsuren B; Chaurasiya B; Ye Z; Liu Y; Li W; Wang C; Shi D; Evans CE; Webster TJ; Shen Y
Int J Nanomedicine; 2020; 15():8201-8215. PubMed ID: 33122906
[TBL] [Abstract][Full Text] [Related]
14. Smart Design of ZnFe and ZnFe@Fe Nanoparticles for MRI-Tracked Magnetic Hyperthermia Therapy: Challenging Classical Theories of Nanoparticles Growth and Nanomagnetism.
Caro C; Guzzi C; Moral-Sánchez I; Urbano-Gámez JD; Beltrán AM; García-Martín ML
Adv Healthc Mater; 2024 May; 13(12):e2304044. PubMed ID: 38303644
[TBL] [Abstract][Full Text] [Related]
15. In Vivo HER2-Targeted Magnetic Resonance Tumor Imaging Using Iron Oxide Nanoparticles Conjugated with Anti-HER2 Fragment Antibody.
Ding N; Sano K; Kanazaki K; Ohashi M; Deguchi J; Kanada Y; Ono M; Saji H
Mol Imaging Biol; 2016 Dec; 18(6):870-876. PubMed ID: 27351762
[TBL] [Abstract][Full Text] [Related]
16. Design of iron oxide-based nanoparticles for MRI and magnetic hyperthermia.
Blanco-Andujar C; Walter A; Cotin G; Bordeianu C; Mertz D; Felder-Flesch D; Begin-Colin S
Nanomedicine (Lond); 2016 Jul; 11(14):1889-910. PubMed ID: 27389703
[TBL] [Abstract][Full Text] [Related]
17. Bevacizumab and near infrared probe conjugated iron oxide nanoparticles for vascular endothelial growth factor targeted MR and optical imaging.
Lin R; Huang J; Wang L; Li Y; Lipowska M; Wu H; Yang J; Mao H
Biomater Sci; 2018 May; 6(6):1517-1525. PubMed ID: 29652061
[TBL] [Abstract][Full Text] [Related]
18. Iron oxide nanoparticle targeting mechanism and its application in tumor magnetic resonance imaging and therapy.
Wu L; Wang C; Li Y
Nanomedicine (Lond); 2022 Sep; 17(21):1567-1583. PubMed ID: 36458585
[TBL] [Abstract][Full Text] [Related]
19. Magnetic Nanoparticles as MRI Contrast Agents.
Avasthi A; Caro C; Pozo-Torres E; Leal MP; García-Martín ML
Top Curr Chem (Cham); 2020 May; 378(3):40. PubMed ID: 32382832
[TBL] [Abstract][Full Text] [Related]
20. Selective radiofrequency ablation of tumor by magnetically targeting of multifunctional iron oxide-gold nanohybrid.
Beyk J; Tavakoli H
J Cancer Res Clin Oncol; 2019 Sep; 145(9):2199-2209. PubMed ID: 31309302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
